Log In
BCIQ
Print this Print this
 

Circadin, melatonin

  Manage Alerts
Collapse Summary General Information
Company Neurim Pharmaceuticals Ltd.
DescriptionControlled-release melatonin
Molecular Target Melatonin MT1 receptor ; Melatonin MT2 receptor
Mechanism of ActionMelatonin MT2 receptor agonist; Melatonin MT1 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInsomnia
Indication DetailsTreat insomnia
Regulatory Designation
PartnerH. Lundbeck A/S;
Teva Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2009

Undisclosed

Undisclosed

0

Get a free BioCentury trial today